Date: 2016-01-07
Type of information: Company acquisition
Acquired company: Anterios (USA - NY)
Acquiring company: Allergan (Ireland)
Amount: upfront payment of $90 million and potential development and commercialization milestone payments
Terms: * On January 7, 2016, Allergan announced that it has acquired Anterios, a clinical stage biopharmaceutical company developing a next generation delivery system and botulinum toxin-based prescription products. Under the terms of the agreement, Allergan acquired Anterios for an upfront payment of $90 million and potential development and commercialization milestone payments related to NDS™, Anterios' proprietary platform delivery technology that enables local, targeted delivery of neurotoxins through the skin without the need for injections.
In addition to NDS™, Allergan has acquired global rights to ANT-1207, an investigational topical formulation botulinum toxin type A in development for the potential treatment of hyperhidrosis (excessive sweating), acne, and crow's feet lines.
Prior to the closing, Anterios spun out certain assets to a new company, Eirion Therapeutics, funded by Anterios shareholders. The new entity also retains certain non-exclusive rights to ANT-1207.
Details: Anterios is a clinical stage biopharmaceutical company developing a next generation delivery system and botulinum toxin-based prescription products. NDS™ is Anterios' proprietary platform delivery technology that enables local, targeted delivery of neurotoxins through the skin without the need for injections.
ANT-1207 is an investigational topical formulation botulinum toxin type A in development for the potential treatment of hyperhidrosis (excessive sweating), acne, and crow's feet lines.
The NDS™ platform technology and ANT-1207 add to Allergan's strong neurotoxin pipeline, with Botox® Cosmetic (onabotulinumtoxinA) currently in development for treating forehead lines, masseter hypertrophy and platysma bands and Botox® Therapeutic in development for osteoarthritis and depression.
Related: Dermatological diseases Aesthetic medicine
